Drug Information

Drug General Information
Drug ID
D07JKY
Former ID
DIB009207
Drug Name
KP-496
Indication Asthma [ICD10:J45] Phase 2 [528550]
CAS Number
CAS 192814-01-0
Target and Pathway
Target(s) Cysteinyl leukotriene receptor 1 Target Info Modulator [528550]
Thromboxane A2 receptor Target Info Modulator [528550]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interactionhsa04020:Calcium signaling pathway
Neuroactive ligand-receptor interaction
Platelet activation
NetPath Pathway TGF_beta_Receptor Signaling Pathway
IL4 Signaling Pathway
IL3 Signaling Pathway
Pathway Interaction Database Endothelins
Reactome Leukotriene receptors
G alpha (q) signalling eventsR-HSA-391908:Prostanoid ligand receptors
G alpha (q) signalling events
G alpha (12/13) signalling events
Thromboxane signalling through TP receptor
WikiPathways GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
Signal amplification
GPCR downstream signaling
References
Ref 528550Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea. Allergol Int. 2006 Dec;55(4):403-10.
Ref 528550Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea. Allergol Int. 2006 Dec;55(4):403-10.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.